Lung transplantation for childhood diffuse lung disease.

Area of Science:

• Pediatric Pulmonology
• Thoracic Surgery
• Transplantation Medicine

Background:

• Pediatric diffuse lung diseases (DLD) are rare, heterogeneous disorders.
• These conditions can lead to end-stage lung disease requiring lung transplantation.
• Limited data exists on DLD outcomes due to small patient cohorts.

Purpose of the Study:

• To compare pre- and post-transplant factors in pediatric patients with DLD undergoing lung transplantation.
• To evaluate DLD outcomes against other end-stage lung disorders like cystic fibrosis (CF) and pulmonary vascular disease (PVD).

Main Methods:

• Retrospective chart review of lung transplant recipients from 2002-2007 at two major pediatric centers.
• Comparison of pre-transplant characteristics and post-transplant outcomes among DLD, CF, and PVD groups.

Main Results:

• DLD patients showed higher pre-transplant morbidity, including lower FEV1, pulmonary hypertension, and hypercapnia.
• More DLD and PVD patients required intensive care unit (ICU) admission and mechanical ventilation compared to CF patients.
• While acute rejection rates differed, survival, infection rates, and post-transplant lymphoproliferative disease were similar across groups.

Conclusions:

• Lung transplantation is a successful treatment option for pediatric patients with end-stage diffuse lung disease.
• Outcomes for DLD patients are comparable to those with cystic fibrosis and pulmonary vascular disease post-transplantation.